Tolterodine Impurity D is a fully hydrogenated derivative of the parent drug, featuring a 1,2,3,4-tetrahydro-8-methyl-2-oxo-2H-8-quinolinyl scaffold with a dimethylamide side chain. The absence of aromatic conjugation in the tetrahydroquinoline core distinguishes it structurally. This impurity arises from incomplete hydrogenation during synthetic processes, retaining the key amide functionality critical for pharmacophore interactions. It serves as an HPLC reference standard for quantifying process-related impurities in tolterodine formulations.
On RequestCC1=CC(=C(C=C1)OC)C(CCNC(C)C)C2=CC=CC=C2
InChI=1S/C20H27NO/c1-15(2)21-13-12-18(17-8-6-5-7-9-17)19-14-16(3)10-11-20(19)22-4/h5-11,14-15,18,21H,12-13H2,1-4H3
DPTHIYCZGOKIDH-UHFFFAOYSA-N